Hypertension in Intensive Care Unit Patients.

Öz

Arterial hypertension, also has higher incidence in normal population, is a common problem in intensive care unit.  However the data regarding HT are particularly about the outpatients, who have variety of cardiovascular risks and it had remained limited in ICU patients. The ignoring of HT involuntary by health professionals who fight with the more complicated life threatening problems, the existence of different medical conditions of patients and variety of each individual needs can lead this situation. Despite of these difficulties, it is expected that the clinician should be successful to do correct action completely in management of HT like a lot of the other medical conditions. In this review, the evaluation and treatment of HT in ICU is examined in light of recent data.

Anahtar Kelimeler

• Hypertension,Intensive Care Unit,Adult Patient

Yoğun Bakım Hastalarında Hipertansiyon

Öz

Hipertansiyon normal popülasyonda olduğu gibi, yoğun bakım hastalarında da sık karşılaşılan önemli bir problemdir. Ancak hipertansiyonla ilgili şu ana kadar literatürde oluşmuş bilgi birikimi daha ziyade ayaktan takip edilen kardiyovasküler riski orta ve yüksek olan hasta gruplarında yoğunlaşmış, yoğun bakım hastalarında sınırlı kalmıştır. Yaşamı tehdit eden öncelikli sorunların çözümü için uğraşan sağlık ekibi tarafından hipertansiyonun istemsiz göz ardı edilmesi, takip edilen her hastanın bireysel özelliklerinin ve medikal destek ihtiyaçlarının çeşitliliği bu duruma yol açıyor olabilir.  Bu zorluklara rağmen yoğun bakımda çalışan klinisyenden birçok konuda olduğu gibi hipertansiyonun yönetimi konusunda da doğru olanı eksiksiz yapması beklenmektedir.  Bu derlemede eldeki veriler ışığında yoğun bakım hastalarında hipertansiyonun değerlendirilmesi ve tedavisi irdelenmiştir.

Anahtar Kelimeler

• Hipertansiyon,Yoğun Bakım Ünitesi,Erişkin Hasta

Kaynakça

1. James PA, Oparil S, Carter BL, Cushman WC, Dennison- Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.
2. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357.
3. Jaques H; National Institute for Health and Clinical Ex- cellence (NICE). NICE guideline on hypertension. Eur Heart J. 2013 Feb;34(6):406-8.
4. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS et al. The 2014 Canadian Hyperten- sion Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Car- diol. 2014 May;30(5):485-501.
5. Arıcı M, Birdane A, Güler K,Yıldız BO, Altun B, Ertürk Ş, Aydoğdu S, Özbakkaloğlu M, Ersöz HÖ, Süleyman- lar G, Tükek T,Tokgözoğlu L, Erdem Y,Türk Kardiyoloji Derneği (TKD), Türk İç Hastalıkları Uzmanlık Derneği (TİHUD),Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD), Türk Nefroloji Derneği (TND),Türk Hipertansiyon ve Böbrek Hastalıkları Derneği.Türk hi- pertansiyon uzlaşı raporu. (Turkish hypertension con- sensus report) Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2015;43(4):402–409
6. Ahmed MEK, Walker JM, Beevers D6, Beevers M. Lack of difference between malignant and accelerated hy- pertension. Br. Med J 1986; 292: 235-237.
7. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043
8. Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, Sindel S, Erbay B, Hasanoğlu E, Cağlar S; for the Turkish Society of Hypertension and Renal Dise- ases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. Journal of Hypertension. 2005;23:1817-1823.

9. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949-62. (4)
10. Frank, M; Bobrie, G; Azizi, M; Peyrard, S; Plouin, PF. Clinical Profile of Patients Referred to A Tertiary Hy- pertension Unit in A City Area. Journal of Hyperten- sion. June 2010, 28:e264.
11. Slama M, Modeliar SS Hypertension in the intensive care unit. Curr Opin Cardiol. 2006 Jul;21(4):279-87.
12. Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 1992; 20:1637– 1643.
13. Prys-Rroberts C. Anaesthesia and hypertension. Br J Anaesth 1984;56:711–724
14. Toraman F, Karabulut H, Goksel O, et al. Comparison of antihypertensives after coronary artery surgery. Asian Cardiovasc Thorac Ann 2005; 13:302–306.
15. Which anticonvulsant for women with eclampsia? Evi- dence from the Collaborative Eclampsia Trial. Lancet 1995; 345:1455–1463.
16. Briones-Garduno JC, Gomez-Bravo Topete E, Avila- Esquivel F, Diaz de Leon-Ponce M. TOLUCA experience in preeclampsia–eclampsia [in Spanish]. Cir Cir 2005; 73:101–105.
17. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the preven- tion of eclampsia. N Engl J Med 1995; 333:201–205.
18. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies.J Am Soc Nephrol 1998; 9:133–142.
19. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Man- ning RD, Norman RA. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972; 52: 5; 584-594.
20. Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989; 2:486.
21. Varon J, Strickman NE. Diagnosis and treatment of hy- pertensive crises in the elderly patients. J Geriatr Car- diol 2007;4:50-55.
22. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-7
23. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a system- atic review of the literature. J Gen Intern Med 2002; 17:937.
24. Zeller KR, Von Kuhnert L, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med 1989; 149:2186.
25. O’Mailia JJ, Sander GE, Giles TD. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med 1987; 107:185.
26. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine cap- sules given for hypertensive emergencies and pseu- doemergencies? JAMA 1996; 276:1328.
27. Prêtre R, Von Segesser LK. Aortic dissection. Lancet 1997; 349:1461. (5)
28. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT et al. Recommendations for the manage- ment of cerebral and cerebellar infarction with swell- ing: a statement for healthcare professionals from the American Heart Association/American Stroke Associa- tion. Stroke. 2014 Apr;45(4):1222-38.
29. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38:1655
30. National Institute for Health and Clinical Excellence. Stroke: The diagnosis and acute management of stroke and transient ischaemic attacks. Royal College of Physicians, London 2008.
31. Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M et al. Guidelines for the Management of Spontaneous Intracerebral Hemor- rhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke As- sociation. Stroke. 2015 May 28.
32. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemor- rhage in adults: 2007 update. Stroke 2007; 38: 2001.
33. Schmidt JM, Ko SB, Helbok R, et al. Cerebral perfu- sion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hem- orrhage. Stroke 2011; 42:1351.
34. Van Gijn J. Subarachnoid haemorrhage. Lancet 1992; 339:653.
35. Jeffrey L. Anderson, Cynthia D. Adams, Elliott M. Ant- man, Charles R. Bridges, Robert M. Califf, Donald E. Casey, Jr., William E. Chavey II, Francis M. Fesmire, Judith S. Hochman, Thomas N. Levin, A. Michael Lin- coff, Eric D. Peterson, Pierre Theroux, Nanette Kass Wengerand R. Scott Wright. ACC/AHA 2007 Guide- lines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: Ex- ecutive Summary. Circulation. 2007;116:803-877.
36. Kaplan, NM. Hypertensive crises. In: Kaplan’s Clinical Hypertension, 9th ed, Neal, W (Ed), Lippincott, Wil- liams and Wilkins, Baltimore 2006. p.311.
37. Visintin C, Mugglestone MA, Almerie MQ, et al. Man- agement of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010; 341:c2207.
38. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100:369.
39. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during preg- nancy. Cochrane Database Syst Rev 2006; :CD001449.
40. Committee on Obstetric Practice. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol 2011; 118:1465.
41. Houston MC. Abrupt cessation of treatment in hy- pertension: consideration of clinical features, mecha- nisms, prevention and management of the discontin- uation syndrome. Am Heart J 1981; 102:415.
42. Miller RR, Olson HG, Amsterdam EA, Mason DT. Pro- pranolol-withdrawal rebound phenomenon. Exacer- bation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 1975; 293:416.
43. Prichard BN, Ross EJ. Use of propranolol in conjunc- tion with alpha receptor blocking drugs in pheochro- mocytoma. Am J Cardiol 1966; 18:394.
44. Brown H, Goldberg PA, Selter JG, et al. Hemorrhagic pheochromocytoma associated with systemic corti- costeroid therapy and presenting as myocardial in- farction with severe hypertension. J Clin Endocrinol Metab 2005; 90:563.
45. Krukemyer JJ, Boudoulas H, Binkley PF, Lima JJ. Com- parison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences. Am Heart J 1990; 120:572.
46. Wu MM, Chanmugam A: Hypertension. In Tintinalli JE, Kelen GD,Stapczynski JS (eds): Emergency Medicine A Comprehensive Study Guide. 6th ed. New York: The Mc Graw Hill Companies, 2003, Sayfa:394- 404.
47. Robin ED, McCauley R. Nitroprusside-related cyanide poisoning: time (long past due. for urgent, effective interventions: Chest 1992; 102:1842-1845.
48. Friederich JA, Butterworth JF. Sodium nitroprusside: twen- ty years and counting. Anesth Analg 1995;81: 152-162.
49. Santhi R, Worthley LIG. Hypertension in the Critically Ill Patient. Critical Care and Resuscitation 2003; 5: 24-42.